Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients
Authors:
- Vincent AudardVAVincent Audard
- Sophie CaillardSCSophie Caillard
- Bruno MoulinBMBruno Moulin
- Dominique DesvauxDDDominique Desvaux
- Bouteina BentaaritBBBouteina Bentaarit
- Philippe RemyPRPhilippe Remy
- Dil SahaliDSDil Sahali
- Françoise Roudot-ThoravalFRFrançoise Roudot-Thoraval
- Philippe LangPLPhilippe Lang
- Philippe GrimbertPGPhilippe Grimbert
- 19 December 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (4) , 1053-1059
Abstract
Recurrence of nephrotic syndrome (NS) after renal transplantation for primary focal segmental glomerulosclerosis (FSGS) is a frequent and still unpredictable complication. However, risk factors for recurrence have not yet been clearly identified. Data from 33 patients who underwent 35 renal transplantations for FSGS in two French centres are reported. Recurrent NS occurred in 12 transplant recipients (34%). A significantly higher number of patients in the group with recurrence (R group) compared with the group without recurrence (NR group) received cyclosporine for FSGS treatment before transplantation (83.3% vs 43.4%, P<0.02). Donors of R group recipients were significantly older than those of the non-NR group recipients (42.8 years vs 35 years, P<0.05). A higher number of patients from the R group required post-transplantation dialysis (33.3% vs 17.4%, P = 0.002). Surprisingly, acute rejection occurred more frequently in patients of the NR group compared with the R group, although the difference was not significant. Among the 12 patients with NS relapse, 9 were treated with plasmapheresis. Graft loss related to recurrence occurred in 6 cases. The 5-year graft survival was significantly lower in patients with recurrent NS compared with patients without recurrence (57% vs 82%, P<0.001). This study confirms the benefit to identify in the future clinical or biological predictive risk factors for NS recurrence after renal transplantation. It also indicates that donor age is a reliable risk factor for recurrence in adult recipients and suggests for the first time a possible opposite relationship between recurrent FSGS and acute rejection.Keywords
This publication has 34 references indexed in Scilit:
- Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in childrenTransplantation, 2003
- Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitorsTransplant International, 2000
- Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejectionKidney International, 1994
- Pefloxacin as first-line treatment in nephrotic syndromeThe Lancet, 1992
- RECURRENT NEPHROTIC SYNDROME FOLLOWING RENAL TRANSPLANTATION IN PATIENTS WITH FOCAL GLOMERULOSCLEROSISTransplantation, 1991
- INCIDENCE, TREATMENT, AND OUTCOME OF RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS POSTTRANSPLANTATION IN 42 ALLOGRAFTS IN CHILDRENTransplantation, 1991
- THE RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINETransplantation, 1990
- PLASMA EXCHANGE FOR RECURRENT NEPHROTIC SYNDROME FOLLOWING RENAL TRANSPLANTATIONTransplantation, 1988
- INCIDENCE AND SIGNIFICANCE OF RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1981
- RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN RENAL ALLOGRAFTSTransplantation, 1981